Rituximab en el manejo de miositis refractaria: a propósito de dos casos / Rituximab in the treatment of refractory myositis: on purpose of two cases
Rev. Soc. Peru. Med. Interna
;
23(3): 109-111, jul.-sept. 2010.
Article
in Spanish
| LILACS, LIPECS
| ID: lil-568280
RESUMEN
Se presenta dos casos de miositis, uno con dermatomiositis y otro con polimiositis, que fueron refractarios al tratamiento con esteroides (prednisona y metilprednisolona) y citotóxicos (aziatropina y ciclofosfamida). Se administró rituximab y se obtuvo mejoría clínica y disminución de las actividades enzimáticas en las semanas siguientes.
ABSTRACT
It is showed two cases of miositis (one with dermatomyositis and another with polimyositis) that did not respond to treatment with steroids (prednisone and metylprednisolone) and cytotoxic drugs (azatioprine and cyclophosphamide). Rituximab was administered and a good clinical response and diminished enzymatic activities were obtained on the following weeks.
Search on Google
Index:
LILACS (Americas)
Main subject:
Steroids
/
Azathioprine
/
Polymyositis
/
Cyclophosphamide
/
Dermatomyositis
/
Antibodies, Monoclonal
/
Myositis
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. Soc. Peru. Med. Interna
Year:
2010
Type:
Article
Institution/Affiliation country:
Universidad Peruana Cayetano Heredia/PE
Similar
MEDLINE
...
LILACS
LIS